Meanings
- uncountablemedicineA human monoclonal antibody being developed to treat rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
As another interleukin 12/23 antagonist, briakinumab, was withdrawn from further development in part due to concerns about cardiovascular safety, discussion has also emerged on cardiovascular safety of ustekinumab.
2015 December 4, “Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients”, in PLOS ONE, →DOI
Origin
From -kin- (“interleukin”) + -umab (“human monoclonal antibody”).
Full word history & related roots →Cite this entry
briakinumab. (n.d.). In WatkinsX Dictionary. Retrieved November 4, 2026, from https://dictionary.watkinsx.com/word/briakinumab
“briakinumab.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/briakinumab. Accessed November 4, 2026.
WatkinsX Dictionary, s.v. “briakinumab,” accessed November 4, 2026, https://dictionary.watkinsx.com/word/briakinumab.
Source: briakinumab on Wiktionary, CC BY-SA 4.0.